Title : Interim Clinical Commissioning Policy: Casirivimab and imdevimab for patients hospitalised due to COVID-19
Description : Interim Clinical Commissioning Policy: Casirivimab and imdevimab for patients hospitalised due to COVID-19
External : True
Version :
Tags : Casirivimab and imdevimab for patients hospitalised due to COVID-19, WAHT-PHA-026
Modified Date and Time : 21/06/2022 12:49:05